Biologically Active Small Molecules

An internal standard for the quantification of 17(R)-RvD1 by GC- or LC-MS.

An internal standard for the quantification of 17(R)-RvD1 by GC- or LC-MS.

A primary mono-oxygenation product of DHA in human whole blood, human leukocytes, and mouse brain serves as a precursor to 17(S)-resolvins.

A primary mono-oxygenation product of DHA in human whole blood, human leukocytes, and mouse brain serves as a precursor to 17(S)-resolvins.

A primary mono-oxygenation product of DHA in human whole blood, human leukocytes, and mouse brain serves as a precursor to 17(S)-resolvins.

A primary mono-oxygenation product of DHA in human whole blood, human leukocytes, and mouse brain serves as a precursor to 17(S)-resolvins.

A minorCYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

A minorCYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

A minorCYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

A mono-oxygenation product of DHA in human whole blood, human leukocytes, human glial cells, and mouse brain that is generally reduced to 17(S)-HDHA (Item No. 10009799) in vivo.

A mono-oxygenation product of DHA in human whole blood, human leukocytes, human glial cells, and mouse brain that is generally reduced to 17(S)-HDHA (Item No. 10009799) in vivo.

A mono-oxygenation product of DHA in human whole blood, human leukocytes, human glial cells, and mouse brain that is generally reduced to 17(S)-HDHA (Item No. 10009799) in vivo.